Skip to content

Clinical Study on the Effect of Digital Human Intelligent Teaching of Baduanjin on Cardiac Rehabilitation in Patients with Chronic Heart Failure

Clinical Study on the Effect of Digital Human Intelligent Teaching of Baduanjin on Cardiac Rehabilitation in Patients with Chronic Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001031
Enrollment
Unknown
Registered
2025-05-26
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure(CHF)

Interventions

Control Group:Implement moderate-intensity aerobic walking in combination with standard Western medicine treatment (referencing the China Heart Failure Diagnosis and Treatment Guidelines 2024) guided
Intervention Group:On the basis of standardized Western medical treatment (referencing the China Heart Failure Diagnosis and Treatment Guidelines 2024), Baduanjin AI-powered digital teaching system wi

Sponsors

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: (1) Age between 40 and 75 years; (2) Diagnosed with chronic heart failure (CHF) according to Western medicine criteria; (3) Identified as having a Qi deficiency and blood stasis syndrome according to Traditional Chinese Medicine (TCM) diagnosis; (4) Cardiac function classified as NYHA II-III; (5) Currently engaged in physical exercise for less than 60 minutes per week; (6) Signed informed consent form.

Exclusion criteria

Exclusion criteria: (1) Restricted limb mobility; (2) Hypertensive patients with poorly controlled blood pressure (systolic blood pressure =180 mmHg or diastolic blood pressure =100 mmHg); (3) Acute exacerbation of chronic heart failure; (4) Resting heart rate exceeding 100 beats per minute or presence of severe arrhythmias (atrial fibrillation with rapid ventricular rate ventricular fibrillation ventricular tachycardia etc.); (5) Absolute contraindications for cardiopulmonary exercise testing or exercise training programs; (6) Severe infections chronic obstructive pulmonary disease respiratory failure or cor pulmonale; (7) Severe primary hepatic renal or hematological diseases or severe psychiatric disorders or uncontrolled systemic diseases; (8) Comorbid severe metabolic disorders (e.g. thyrotoxicosis diabetic ketoacidosis); (9) Currently undergoing rehabilitation exercise therapy including traditional Chinese Daoyin training (e.g. Baduanjin Yijinjing Wuqinxi etc.). Participants meeting any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Minnesota Living with Heart Failure Questionnaire scores;90-day Readmission Rate;

Secondary

MeasureTime frame
Left Ventricular Ejection Fraction(LVEF);Metabolic Equivalent of Task;Traditional Chinese Medicine Syndrome Score (TCMSS);NT-proBNP(N-terminal pro-B-type Natriuretic Peptide);Balance Assessment(BA);Blood Lipid Levels;Cardiometabolic Index;Ventilatory Anaerobic Threshold;Six-Minute Walk Test;High-Sensitivity C-Reactive Protein;Maximal Oxygen Uptake;Heart Rate Variability;

Countries

China

Contacts

Public ContactShengLei Qiu

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

choushenglei@bjzhongyi.com13426241268

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026